United States

NxStage Medical posts Q2 loss of $0.03 per share

Monday, 7 Aug 2017 02:15am EDT 

Aug 7 (Reuters) - Nxstage Medical Inc :NxStage reports second quarter financial results.Q2 revenue $96.2 million versus I/B/E/S view $96.5 million.NxStage Medical - in light of acquisition agreement between Fresenius Medical Care and NxStage, NxStage is no longer providing financial guidance.Has canceled its previously announced conference call to discuss its financial results for Q2 of 2017.Qtrly loss per share $0.03.